Koyfin Home > Directory > Health Care > Albireo Pharma Inc > Cash Flow from Operations

Albireo Pharma Inc Cash Flow from Operations Chart (ALBO)

Albireo Pharma Inc annual/quarterly Cash Flow from Operations from 2015 to 2020. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Albireo Pharma Inc Cash Flow from Operations for the quarter ending June 06, 2020 was $-23m a 39.28% decrease of -9m year over year
  • Albireo Pharma Inc Cash Flow from Operations for the last 12 months ending June 06, 2020 was $-73m a 31.05% decrease of -23m year over year
  • Albireo Pharma Inc Annual Cash Flow from Operations for 2019 was $-53m a 49.35% decrease of -26m from 2018
  • Albireo Pharma Inc Annual Cash Flow from Operations for 2018 was $-27m a -2.85% increase of 1m from 2017
  • Albireo Pharma Inc Annual Cash Flow from Operations for 2017 was $-28m a 68.13% decrease of -19m from 2016
Other Cash Flow Metrics:
  • Albireo Pharma Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-10m a 91.45% decrease of -10m year over year
  • Albireo Pharma Inc Total Revenue for the quarter ending September 09, 2018 was $0m a 100.42% increase of 0m year over year
View Chart On Koyfin

Quarterly ALBO Cash Flow from Operations Data

06/2020$-23m
03/2020$-24m
12/2019$-12m
09/2019$-14m
06/2019$-13m
03/2019$-14m
12/2018$-10m
09/2018$-10m
06/2018$-8m
03/2018$1m

Annual ALBO Cash Flow from Operations Data

2019$-53m
2018$-27m
2017$-28m
2016$-9m
2015$-5m
2014$-6m